Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Irene Delgado Sillero"'
Autor:
Irene Delgado Sillero, Nerea Lopetegui Lia, Luis Felipe Sánchez Cousido, Mariam Rojas Piedra, Blanca Távara Silva, Maria Luisa Garrido Onecha, Soledad Medina Valdivieso, Nieves Alonso Horcajo, Cristina Díez Tascón, Ana López González, Carmen Castañón López, Manuela Pedraza Lorenzo, Andrés García Palomo, Vicente Martín, Pilar Diz Tain
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.
Introduction 10–16% of non-small cell lung cancer (NSCLC) cases have the epidermal growth factor receptor (EGFR) amplified and/or mutated. Studies show that EGFR tyrosine kinase inhibitors (TKIs) significantly prolong progression-free survival (PFS
Autor:
Laura López-González, Irene Delgado Sillero, Ana Lopez-Gonzalez, Andres Garcia Palomo, Mariana Lopez Flores
Publikováno v:
Breast Cancer Management. 6:113-115
Fulvestrant is indicated in the treatment of locally advanced or metastatic breast cancer in postmenopausal women with hormone receptor-positive breast cancer as second line at the present time, after first line hormone therapy. We present here a cas
Autor:
Ricardo Suárez-Fernández, Irene Delgado-Sillero, Petunia Clavo, Elena Conde-Montero, Celia Horcajada-Reales
Publikováno v:
International Wound Journal. 13:726-728
Neuropathic ulcers in leprosy represent a therapeutic challenge for clinicians. Chronic ulcers affect patient health, emotional state and quality of life, causing considerable morbidity and mortality in addition to contributing to significant health